Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dentistry
Volume 2014 (2014), Article ID 384292, 5 pages
http://dx.doi.org/10.1155/2014/384292
Case Report

Clinical Aspects, Imaging Features, and Considerations on Bisphosphonate-Related Osteonecrosis Risk in a Pediatric Patient with Osteogenesis Imperfecta

1Division of Oral Radiology, Department of Clinical Dentistry, Federal University of Ceará, Rua Alexandre Baraúna 949, 60430-160 Fortaleza, CE, Brazil
2Division of Stomatology and Oral Radiology, Department of Clinical Dentistry, Federal University of Ceará, Rua Alexandre Baraúna 949, 60430-160 Fortaleza, CE, Brazil
3Division of Stomatology, Department of Clinical Dentistry, Federal University of Ceará, Rua Alexandre Baraúna 949, 60430-160 Fortaleza, CE, Brazil
4Division of Oral and Maxillofacial Surgery, Department of Oral and Maxillofacial Surgery, Walter Cantídio University Hospital, Federal University of Ceará, Rua Alexandre Baraúna 949, 60430-160 Fortaleza, CE, Brazil
5Division of Oral Pathology and Stomatology, Department of Clinical Dentistry, Federal University of Ceará, Rua Alexandre Baraúna 949, 60430-160 Fortaleza, CE, Brazil
6Division of Oral and Maxillofacial Surgery, Department of Oral and Maxillofacial Surgery, Federal University of Rio Grande do Norte, Campus Universitário Lagoa Nova, 59078-900 Natal, RN, Brazil
7Division of Pediatric Dentistry, Department of Clinical Dentistry, Federal University of Ceará, Rua Alexandre Baraúna 949, 60430-160 Fortaleza, CE, Brazil

Received 3 May 2014; Accepted 12 August 2014; Published 26 August 2014

Academic Editor: Tommaso Lombardi

Copyright © 2014 Fábio Wildson Gurgel Costa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Chen, S. Lin, Y. Su et al., “Osteogenesis imperfecta type IV: prenatal molecular diagnosis and genetic counseling in a pregnancy carried to full term with favorable outcome,” Taiwanese Journal of Obstetrics and Gynecology, vol. 51, no. 2, pp. 271–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. C. O'Connell and J. C. Marini, “Evaluation of oral problems in an osteogenesis imperfecta population,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 87, no. 2, pp. 189–196, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. L. Ruggiero, T. B. Dodson, L. A. Assael, R. Landesberg, R. E. Marx, and B. Mehrotra, “American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, pp. 2–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. M. Ward, F. Rauch, M. P. Whyte et al., “Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 2, pp. 355–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. L. Ruggiero, T. B. Dodson, L. A. Assael et al., “American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 3, pp. 369–376, 2007. View at Google Scholar
  6. S. Schwartz, C. Joseph, D. Iera, and D. Vu, “Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series,” Journal of the Canadian Dental Association, vol. 74, no. 6, pp. 537–542, 2008. View at Google Scholar · View at Scopus
  7. P. Surendra, R. Shah, N. M. Roshan, and V. V. Subba Reddy, “Dentinogenesis imperfecta: a family which was affected for over three generations,” Journal of Clinical and Diagnostic Research, vol. 7, no. 8, pp. 1808–1811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. L. Ruggiero, B. Mehrotra, T. J. Rosenberg, and S. L. Engroff, “Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases,” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 5, pp. 527–534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Bishop, S. Adami, S. F. Ahmed et al., “Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 382, no. 9902, pp. 1424–1432, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. L. Watters, H. J. Hansen, T. Williams et al., “Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 115, no. 2, pp. 192–200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Yoneda, H. Hagino, T. Sugimoto et al., “Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied task force committee of Japanese society for bone and mineral research, Japan osteoporosis society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons,” Journal of Bone and Mineral Metabolism, vol. 28, no. 4, pp. 365–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Migliorati, J. Casiglia, J. Epstein, P. L. Jacobsem, M. A. Siegel, and S. Woo, “Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper,” Journal of the American Dental Association, vol. 136, no. 12, pp. 1658–1668, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Lee, R. C. Chan, S. S. Chang et al., “Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies,” Support Care Cancer, vol. 22, no. 2, pp. 553–560, 2014. View at Google Scholar
  14. D. O. Sillence, A. Senn, and D. M. Danks, “Genetic heterogeneity in osteogenesis imperfecta,” Journal of Medical Genetics, vol. 16, no. 2, pp. 101–116, 1979. View at Publisher · View at Google Scholar · View at Scopus
  15. L. S. Levin, J. M. Brady, and M. Melnick, “Scanning electron microscopy of teeth in dominant osteogenesis imperfecta: support for genetic heterogeneity,” The American Journal of Medical Genetics, vol. 5, no. 2, pp. 189–199, 1980. View at Publisher · View at Google Scholar · View at Scopus
  16. C. R. Paterson, S. McAllion, and R. Miller, “Osteogenesis imperfecta with dominant inheritance and normal sclerae,” Journal of Bone and Joint Surgery B, vol. 65, no. 1, pp. 35–39, 1983. View at Google Scholar · View at Scopus
  17. F. H. Glorieux, F. Rauch, H. Plotkin et al., “Type V osteogenesis imperfecta: a new form of brittle bone disease,” Journal of Bone and Mineral Research, vol. 15, no. 9, pp. 1650–1658, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. F. H. Glorieux, L. M. Ward, F. Rauch, L. Lalic, P. J. Roughley, and R. Travers, “Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect,” Journal of Bone and Mineral Research, vol. 17, no. 1, pp. 30–38, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. L. M. Ward, F. Rauch, R. Travers et al., “Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease,” Bone, vol. 31, no. 1, pp. 12–18, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. W. A. Cabral, W. Chang, A. M. Barnes et al., “Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta,” Nature Genetics, vol. 39, no. 3, pp. 359–365, 2007. View at Publisher · View at Google Scholar · View at Scopus